Michael Raya said: 
“The GPhA’s Board and professional staff are terrific stewards of the industry. I am honored to add my voice to GPhA’s leadership on critical issues of medicine access and affordability.”

Chip Davis, President and CEO, GPhA, said: 
“Michael Raya is a proven industry leader whose addition to our Board will accelerate our work with Congress, the FDA, stakeholders and others to ensure that generic drugs and biosimilars continue providing millions of Americans with safe, effective and more affordable alternatives to costly brand products.”